ANI Pharmaceuticals initiated with a Buy at Guggenheim
The Fly

ANI Pharmaceuticals initiated with a Buy at Guggenheim

Related Articles
TheFlyANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
TheFlyANI Pharmaceuticals completes acquisition of Alimera Sciences
GlobeNewswireANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App